FDMT R&D Expenses
4D Molecular Therapeutics Inc · R&D Expenses
FDMT R&D Expenses
Latest reported$240.31Mperiod ending
FDMT TTM R&D Expenses ($18.36M → $240.31M)
TTM R&D Expenses
High-resolution chart · PNG
FDMT r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 240,308,000 | |
| 219,977,000 | |
| 195,696,000 | |
| 181,173,000 | |
| 170,219,000 | |
| 154,128,000 | |
| 141,299,000 | |
| 124,242,000 | |
| 110,824,000 | |
| 102,548,000 | |
| 97,090,000 | |
| 92,562,000 | |
| 86,436,000 | |
| 83,274,000 | |
| 80,243,000 | |
| 76,271,000 | |
| 73,171,000 | |
| 67,972,000 | |
| 61,360,000 | |
| 56,437,000 | |
| 52,152,000 | |
| 52,649,000 | |
| 53,038,000 | |
| 52,792,000 | |
| 50,611,000 | |
| 43,383,500 | |
| 38,718,000 | |
| 31,436,000 | |
| 27,139,000 | |
| 22,750,500 | |
| 18,362,000 |